• Japanese
  • Korean
  • Chinese
Cover Image

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012

Abstract

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, "Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012" provides data on the Small-Cell Lung Cancer/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small-Cell Lung Cancer/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Small-Cell Lung Cancer/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Small-Cell Lung Cancer/Impaired Glucose Tolerance Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Small-Cell Lung Cancer/Impaired Glucose Tolerance, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

TOC

Table of Contents

Table of Contents 2

  • List of Tables 5
  • List of Figures 7
  • Introduction 8
  • Small-Cell Lung Cancer 8
  • Report Guidance 8
  • Clinical Trials by Region 9
  • Clinical Trials by Country 10
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by BRIC Nations 17
  • Clinical Trials by G7 Nations 18
  • Clinical Trials in G7 Nations by Trial Status 19
  • Clinical Trials by E7 Nations 20
  • Clinical Trials in E7 Nations by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Unaccomplished Trials of Small-Cell Lung Cancer 25
  • Subjects Recruited Over a Period of Time 30
  • Prominent Sponsors 31
  • Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials 33
  • Prominent Drug Comparison 35
  • Clinical Trial Profiles 36
  • Clinical Trial Overview of Top Companies 36
  • GlaxoSmithKline plc 36
  • Clinical Trial Overview of GlaxoSmithKline plc 36
  • Eli Lilly and Company 37
  • Clinical Trial Overview of Eli Lilly and Company 37
  • Bristol-Myers Squibb Company 38
  • Clinical Trial Overview of Bristol-Myers Squibb Company 38
  • Celgene Corporation 39
  • Clinical Trial Overview of Celgene Corporation 39
  • Pfizer Inc. 40
  • Clinical Trial Overview of Pfizer Inc. 40
  • ZIOPHARM Oncology, Inc. 41
  • Clinical Trial Overview of ZIOPHARM Oncology, Inc. 41
  • ImmunoGen, Inc. 42
  • ImmunoGen, Inc. 42
  • Clinical Trial Overview of ImmunoGen, Inc. 42
  • Amgen Inc. 43
  • Clinical Trial Overview of Amgen Inc. 43
  • Bayer Inc. 44
  • Clinical Trial Overview of Bayer Inc. 44
  • Abbott Laboratories 45
  • Clinical Trial Overview of Abbott Laboratories 45
  • Sanofi 46
  • Clinical Trial Overview of Sanofi 46
  • Nippon Kayaku Co., Ltd. 47
  • Clinical Trial Overview of Nippon Kayaku Co., Ltd. 47
  • Astex Pharmaceuticals, Inc. 48
  • Clinical Trial Overview of Astex Pharmaceuticals, Inc. 48
  • Merck KGaA 49
  • Clinical Trial Overview of Merck KGaA 49
  • Poniard Pharmaceuticals, Inc. 50
  • Clinical Trial Overview of Poniard Pharmaceuticals, Inc. 50
  • UAB Health System 51
  • Clinical Trial Overview of UAB Health System 51
  • CHONG KUN DANG PHARMACEUTICAL CORP. 52
  • Clinical Trial Overview of CHONG KUN DANG PHARMACEUTICAL CORP. 52
  • Cephalon, Inc. 53
  • Clinical Trial Overview of Cephalon, Inc. 53
  • ImClone LLC 54
  • Clinical Trial Overview of ImClone LLC 54
  • Novartis AG 55
  • Clinical Trial Overview of Novartis AG 55
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
  • The University of Texas M. D. Anderson Cancer Center 56
  • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56
  • Southeastern Medical Oncology Center 57
  • Clinical Trial Overview of Southeastern Medical Oncology Center 57
  • Sarah Cannon Research Institute 58
  • Clinical Trial Overview of Sarah Cannon Research Institute 58
  • H. Lee Moffitt Cancer Center & Research Institute 59
  • Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 59
  • Dana-Farber Cancer Institute 60
  • Clinical Trial Overview of Dana-Farber Cancer Institute 60
  • Wake Forest University 61
  • Clinical Trial Overview of Wake Forest University 61
  • Memorial Sloan Kettering Cancer Center 62
  • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62
  • Maastricht Radiation Oncology 63
  • Clinical Trial Overview of Maastricht Radiation Oncology 63
  • Mayo Clinic 64
  • Clinical Trial Overview of Mayo Clinic 64
  • Fox Chase Cancer Center 65
  • Clinical Trial Overview of Fox Chase Cancer Center 65
  • University of Michigan Comprehensive Cancer Center 66
  • Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 66
  • University of Colorado 67
  • Clinical Trial Overview of University of Colorado 67
  • UCLA's Jonsson Comprehensive Cancer Center 68
  • Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 68
  • Stanford University 69
  • Clinical Trial Overview of Stanford University 69
  • Roswell Park Cancer Institute 70
  • Clinical Trial Overview of Roswell Park Cancer Institute 70
  • Case Comprehensive Cancer Center 71
  • Clinical Trial Overview of Case Comprehensive Cancer Center 71
  • UH Seidman Cancer Center 72
  • Clinical Trial Overview of UH Seidman Cancer Center 72
  • Vanderbilt-Ingram Cancer Center 73
  • Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 73
  • Norris Cotton Cancer Center 74
  • Clinical Trial Overview of Norris Cotton Cancer Center 74
  • Tohoku University 75
  • Clinical Trial Overview of Tohoku University 75
  • Five Key Clinical Profiles 76

Appendix 92

  • Abbreviations 92
  • Definitions 92
  • Research Methodology 93
  • Secondary Research 93
  • About GlobalData 94
  • Contact Us 94
  • Disclaimer 94
  • Source 95

List of Tables

List of Tables

  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 17
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 18
  • Small-Cell Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 20
  • Small-Cell Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
  • Small-Cell Lung Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
  • Small-Cell Lung Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
  • Small-Cell Lung Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 30
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 35
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 36
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 37
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 38
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 39
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 40
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARM Oncology, Inc., 2012* 41
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImmunoGen, Inc., 2012* 42
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 43
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer Inc., 2012* 44
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 45
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 46
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Kayaku Co., Ltd., 2012* 47
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astex Pharmaceuticals, Inc., 2012* 48
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2012* 49
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Poniard Pharmaceuticals, Inc., 2012* 50
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UAB Health System, 2012* 51
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by CHONG KUN DANG PHARMACEUTICAL CORP., 2012* 52
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012* 53
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012* 54
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 55
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 56
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012* 57
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 58
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 59
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 60
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 61
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 62
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht Radiation Oncology, 2012* 63
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 64
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012* 65
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 66
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 67
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 68
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 69
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 70
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 71
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UH Seidman Cancer Center, 2012* 72
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012* 73
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Norris Cotton Cancer Center, 2012* 74
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2012* 75

List of Figures

List of Figures

  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
  • Small-Cell Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
  • Small-Cell Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 30
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 35
  • GlobalData Methodology 93
Show More
Pricing
Get Notified
Email me when related reports are published